Health & Medical Archives | Be Korea-savvy

Archive by category Health & Medical

Abiomed Announces Q1 FY 2018 Revenue of $132.5 Million, Up 29% Over Prior Year

Abiomed Announces Q1 FY 2018 Revenue of $132.5 Million, Up 29% Over Prior Year

DANVERS, Mass., Jul. 27 (Korea Bizwire) — Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support technologies, today reported first quarter fiscal 2018 revenue of $132.5 million, an increase of 29% compared to revenue of $103.0 million for the same period of fiscal 2017. First quarter fiscal 2018 GAAP net income was $37.4 million [...]

RedHill Biopharma Reports 2017 Second Quarter Financial Results

RedHill Biopharma Reports 2017 Second Quarter Financial Results

(image: Korea Bizwire) TEL-AVIV, Israel and RALEIGH, N.C., Jul. 25 (Korea Bizwire) — RedHill Biopharma Ltd. (NASDAQ:RDHL) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily focused on late clinical-stage development and commercialization of proprietary, orally-administered, small molecule drugs for gastrointestinal and inflammatory diseases and cancer, today reported its financial results for [...]

Medibio Building Credentials to “Scale” via Appointment of Healthcare & Telehealth Icon to Board of Directors

Medibio Building Credentials to “Scale” via Appointment of Healthcare & Telehealth Icon to Board of Directors

SYDNEY, Australia and MINNEAPOLIS, Jul. 19 (Korea Bizwire) — Medibio Limited (MEB or the Company) (ASX:MEB) (OTCQB:MDBIF), a digital health company that has developed an objective testing system to assist in the screening, diagnosis and treatment effectiveness of depression, chronic stress and other mental health disorders, is pleased to announce the appointment of Dr Adam [...]

RedHill Biopharma Announces Last Patient Visit in BEKINDA® Phase II Study for IBS-D

RedHill Biopharma Announces Last Patient Visit in BEKINDA® Phase II Study for IBS-D

TEL-AVIV, Israel and RALEIGH, N.C., Jul. 17 (Korea Bizwire) — RedHill Biopharma Ltd. (NASDAQ:RDHL) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily focused on late clinical-stage development and commercialization of proprietary, orally-administered, small molecule drugs for gastrointestinal and inflammatory diseases and cancer, today announced that the last patient enrolled in the [...]

FOR SALE: State-of-the-Art cGMP-Qualified Solid Dosage Development and Manufacturing Facility

FOR SALE: State-of-the-Art cGMP-Qualified Solid Dosage Development and Manufacturing Facility

COMMACK, NY, Jul. 13 (Korea Bizwire) — A spacious, technologically advanced facility, conveniently located within an area of robust pharmaceutical initiatives, is now available for cGMP activities, from formulation development to mid-size commercial production.  Ropack Pharma Solutions (RPS) has made the strategic decision to market and sell its 103,530-sq-ft pharmaceutical and research facility on a [...]

The International Association for the Study of Lung Cancer Announces the IASLC 18th World Conference on Lung Cancer

The International Association for the Study of Lung Cancer Announces the IASLC 18th World Conference on Lung Cancer

DENVER, Jul. 13, 2017 (Korea Bizwire) — The International Association for the Study of Lung Cancer (IASLC) announced today that the IASLC 18th World Conference on Lung Cancer (WCLC) will take place on October 15-18, 2017, in Yokohama, Japan. The WCLC is the world’s largest meeting dedicated solely to lung cancer and other thoracic malignancies—gathering over [...]

RedHill Biopharma Announces Expected Timeline for DSMB meeting and Provides Update on Enrollment in the RHB-104 Phase III Study for Crohn’s Disease

RedHill Biopharma Announces Expected Timeline for DSMB meeting and Provides Update on Enrollment in the RHB-104 Phase III Study for Crohn’s Disease

TEL-AVIV, Israel and RALEIGH, N.C., Jul. 12 (Korea Bizwire) — RedHill Biopharma Ltd. (NASDAQ:RDHL) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily focused on the development and commercialization of late clinical-stage, proprietary, orally-administered, small molecule drugs for gastrointestinal and inflammatory diseases and cancer, today announced that the second independent Data and [...]

Labiaplasty Is the World’s Fastest Growing Cosmetic Surgery Procedure, International Study Reports

Labiaplasty Is the World’s Fastest Growing Cosmetic Surgery Procedure, International Study Reports

NEW YORK, Jul. 11 (Korea Bizwire) — The results of an international study recently released by the International Society of Aesthetic Plastic Surgery (ISAPS), that surveyed cosmetic procedures in 106 countries, shows significant growth in a surprising area of cosmetic surgery: labiaplasty. Labiaplasty is a procedure that reduces the length of the labia minora, when [...]

Taconic Biosciences and Pharmatest Services Ltd. Create First Human Immune System Model for Bone Metastasis

Taconic Biosciences and Pharmatest Services Ltd. Create First Human Immune System Model for Bone Metastasis

HUDSON, N.Y., Jul. 5 (Korea Bizwire) — Taconic Biosciences, a global leader in genetically engineered mouse models and associated services, announced it has signed a collaborative agreement with Pharmatest Services, Ltd. (“Pharmatest”) to leverage the company’s oncology and skeletal disease preclinical efficacy services using Taconic’s humanized mouse models. Bone metastasis develops when cancer spreads from [...]

Medibio Appoints Mental Healthcare Advocate and Former Congressman, Patrick Kennedy, to Board of Directors

Medibio Appoints Mental Healthcare Advocate and Former Congressman, Patrick Kennedy, to Board of Directors

SYDNEY, Australia and MINNEAPOLIS, Jul. 5 (Korea Bizwire) — Australian Stock Exchange listed medical technology company Medibio Limited (MEB or the Company) is pleased to announce the appointment of The Honourable Patrick J. Kennedy to the Board of Directors. Patrick J. Kennedy is a former member of the U.S. House of Representatives (D-R.I.) and the [...]